About Us

Dr. Arnon Heyman is the CEO of Canonic Ltd. Dr. Heyman has previously served as VP and GM of Evogene’s Ag-Seeds division managing all plant genetics activities and related collaborations. Prior to Evogene, Dr. Heyman served as CTO of BondX Technologies Ltd. from 2009-2014.

Dr. Heyman holds a PhD. In Biotechnology from the Hebrew University in Jerusalem (2008) and a MBA from the College of Management (2015).

Dr. Inbal Dangoor is an experienced plant scientist with expertise in genetics, biotechnology and computational biology. Prior to joining Canonic, Dr. Dangoor managed the New Breeding Technologies activities of Evogene and was the Corn research team leader in the Yield and Abiotic Stress division.

Dr. Dangoor holds a Ph.D. from the Weizmann Institute of Science in Rehovot (2010).

Elena Huly is heading the branding process of Canonic as a Medical Technology Company with unique technology, and establishes collaborations with strategic partners. In addition, Huly is in charge of supervision of the company’s various suppliers and manages Canonic’s digital assets.

Huly joined Canonic in 2021. She began her professional path in 2014, as a brand and marketing manager at Ice Cube, a women’s clothing chain. In 2018, she worked for Telepharma as a marketing and sales manager, digital marketing and e-commerce manager. As part of her role, Huly established the digital assets of the Epharma, EpharmaB and Green Pharma brands.

Huly holds a B.A. in Psychology from the Open University of Israel (2011).

Guy Adler joined Canonic in August 2020 and is responsible for all of the agricultural-commercial aspects of the company, from the development stage to the product stage, as well as the field of medical cannabis value chain.

Adler has over two decades of experience in the plant world and is an expert in the field of vegetative propagation. He previously worked at a genetics cultivation company where he was exposed to every field and development and commercialization, and was also an agricultural consultant at Zim Shipping.

Guy Adler holds a Bachelor’s and Master’s degree in Agricultural Economics from the Hebrew University of Jerusalem (2007).

Dr. Michi Brog is responsible for plant breeding in Canonic in accordance with product definition, and uses genetic and computational tools to develop medical cannabis strains.

Dr. Brog joined Canonic in 2019. He began his professional career in 2016 at the Evogene company as a trait researcher of agricultural crops and computational genomics. He later moved to Casterra AG Ltd. where he worked as a cultivator.

Dr. Brog holds a Bachelor of Science degree at the Robert H. Smith Faculty of Agriculture, Food and Environment of the Hebrew University of Jerusalem (2007), a Master’s of Science and Doctorate at the Hebrew University of Jerusalem in Genetics and Tomato Enhancement (2013).

Yafit Sugas works in Canonic as a Plant Cultivation Assistant since 2021. In her role she promotes cultivation, hybridization and production programs of medical cannabis strains. Sugas is engaged in preserving the quality of cannabis pollen intended for hybridization, and in optimizing processes to streamline the transition from one seed generation to another.

Sugas holds a Bachelor of Science from the Hebrew University of Jerusalem (2019) and a Master’s of Science at the Robert H. Smith Faculty of Agriculture, Food and Environment of the Hebrew University of Jerusalem (2021).

Yonatan Wegman joined Canonic in 2021 and serves as the Chief Agronomist of the company. In his role, he implements strains treatment programs and is entrusted with the upgrading of plant-growing infrastructures.

Wegman has been involved in agricultural crops since 2015 and worked in the Research and Development department of Hishtil, the Israeli plant propagation company. He later moved to the field of cannabis and worked at BOL, where he managed the field of propagation and planting.

Yonatan Wegman holds a B.A. in Plant Sciences from the Hebrew University of Jerusalem (2015).

Or joined Canonic in 2021, and works at the company as a Plant Technician. In his role, Hariri is responsible for plant growth, cultivation and their enhancement.

Before his role at Canonic, Hariri worked as a Medical Cannabis Grower in the BOL PHARMA company for three years.

Ido Singer has been working at Canonic since 2021, and in his role, he is responsible for the genetic bank of the seeds, cultivation of breeding batches, cuttings, growing mother plants which are rooted for RNB purposes, strain trials and export.

Previously Singer worked in the strawberry strain cultivation at the Carmel Agrexco company, where he managed the plant nursery, attended to cultivation programs, hybridization, pest control and the management of the genetic bank.

Former CEO of Koor Industries

Director of the pain relief unit in Hadassah Medical Center

Director of the Multidisciplinary Center for Cannabinoid Research of the Hebrew University.

Plant Breeding and Product Development of commercial strains with over 30 years of experience in leading multinational seed companies.